<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04536194</url>
  </required_header>
  <id_info>
    <org_study_id>mzk-0003-2020</org_study_id>
    <nct_id>NCT04536194</nct_id>
  </id_info>
  <brief_title>Dopamine Versus Norepinephrine Under General Anesthesia</brief_title>
  <official_title>Hemodynamic Effects of Dopamine Versus Norepinephrine Under General Anesthesia in Infant With Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants under general anesthesia will be randomly treated with an adjusted dose dopamine&#xD;
      or norepinephrine to elevate 10% of mean arterial pressure. Systemic hemodynamic data is&#xD;
      recorded by PRAM and the change of cardiac index is compared between groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After intubation under general anesthesia, radial arterial is cannulated and pressure&#xD;
      transducer is connected to MostCare(core technique PRAM). CI, SVRI, SVI, SVV, dp/dt and HR&#xD;
      are recorded before and after a infusion of dopamine or norepinephrine to elevate 10% of mean&#xD;
      arterial pressure. Changes of these hemodynamic data are compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 10, 2020</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">August 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes of cardiac index</measure>
    <time_frame>20 minutes</time_frame>
    <description>the differences of cardiac index between after and before the intervention (l/min/m2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes of stroke volume index</measure>
    <time_frame>20 minutes</time_frame>
    <description>the differences of stroke volume index between after and before the intervention (ml/m2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes of systemic vascular resistance index</measure>
    <time_frame>20 minutes</time_frame>
    <description>the differences of systemic vascular resistance index between after and before the intervention(dyne ∙ sec ∙ m2/cm5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes of the maximal slope of systolic upstroke</measure>
    <time_frame>20 minutes</time_frame>
    <description>the differences of the maximal slope of systolic upstroke between after and before the intervention(mmHg/ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes of heart rate</measure>
    <time_frame>20 minutes</time_frame>
    <description>the differences of heart rate between after and before the intervention (bpm)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthesia</condition>
  <condition>Infant</condition>
  <condition>Congenital Heart Disease</condition>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>norepinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusion of norepinephrine with a adjusted dose to elevate 10% of mean arterial pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dopamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infusion of dopamine with a adjusted dose to elevate 10% of mean arterial pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>norepinephrine</intervention_name>
    <description>to treat hypotension under general anesthesia with norepinephrine</description>
    <arm_group_label>norepinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dopamine</intervention_name>
    <description>to treat hypotension under general anesthesia with dopamine</description>
    <arm_group_label>Dopamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  undertake cardiac surgery for congenital heart disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Aortic valve or aortic disease&#xD;
&#xD;
          -  severe arrhythmia&#xD;
&#xD;
          -  use of cardiovascular active drugs before anesthesia&#xD;
&#xD;
          -  need to use a combination of different cardiovascular support drugs after anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Yuan SM. Acute kidney injury after pediatric cardiac surgery. Pediatr Neonatol. 2019 Feb;60(1):3-11. doi: 10.1016/j.pedneo.2018.03.007. Epub 2018 Mar 30. Review.</citation>
    <PMID>29891225</PMID>
  </reference>
  <reference>
    <citation>Foulon P, De Backer D. The hemodynamic effects of norepinephrine: far more than an increase in blood pressure! Ann Transl Med. 2018 Nov;6(Suppl 1):S25. doi: 10.21037/atm.2018.09.27.</citation>
    <PMID>30613600</PMID>
  </reference>
  <reference>
    <citation>Cavigelli-Brunner A, Hug MI, Dave H, Baenziger O, Buerki C, Bettex D, Cannizzaro V, Balmer C. Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone. Pediatr Crit Care Med. 2018 Jul;19(7):619-625. doi: 10.1097/PCC.0000000000001533.</citation>
    <PMID>29538053</PMID>
  </reference>
  <reference>
    <citation>Saxena R, Durward A, Steeley S, Murdoch IA, Tibby SM. Predicting fluid responsiveness in 100 critically ill children: the effect of baseline contractility. Intensive Care Med. 2015 Dec;41(12):2161-9. doi: 10.1007/s00134-015-4075-8. Epub 2015 Sep 28.</citation>
    <PMID>26415680</PMID>
  </reference>
  <results_reference>
    <citation>Hamzaoui O, Jozwiak M, Geffriaud T, Sztrymf B, Prat D, Jacobs F, Monnet X, Trouiller P, Richard C, Teboul JL. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth. 2018 Mar;120(3):517-524. doi: 10.1016/j.bja.2017.11.065. Epub 2017 Nov 21.</citation>
    <PMID>29452808</PMID>
  </results_reference>
  <results_reference>
    <citation>Favia I, Rizza A, Garisto C, Haiberger R, Di Chiara L, Romagnoli S, Ricci Z. Cardiac index assessment by the pressure recording analytical method in infants after paediatric cardiac surgery: a pilot retrospective study. Interact Cardiovasc Thorac Surg. 2016 Dec;23(6):919-923. Epub 2016 Aug 1.</citation>
    <PMID>27481679</PMID>
  </results_reference>
  <results_reference>
    <citation>Urbano J, López J, González R, Solana MJ, Fernández SN, Bellón JM, López-Herce J. Measurement of cardiac output in children by pressure-recording analytical method. Pediatr Cardiol. 2015 Feb;36(2):358-64. doi: 10.1007/s00246-014-1014-3. Epub 2014 Sep 2.</citation>
    <PMID>25179459</PMID>
  </results_reference>
  <results_reference>
    <citation>Garisto C, Favia I, Ricci Z, Romagnoli S, Haiberger R, Polito A, Cogo P. Pressure recording analytical method and bioreactance for stroke volume index monitoring during pediatric cardiac surgery. Paediatr Anaesth. 2015 Feb;25(2):143-9. doi: 10.1111/pan.12360. Epub 2014 Feb 3.</citation>
    <PMID>24491036</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2020</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Zhijian Zhou</investigator_full_name>
    <investigator_title>vice director of department of anesthesiology</investigator_title>
  </responsible_party>
  <keyword>norepinephrine</keyword>
  <keyword>dopamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>starting 6 months after publication</ipd_time_frame>
    <ipd_access_criteria>share to researchers by email</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

